NGN ATI RN VATI COMPREHENSIVE PREDICTOR 2025 (LATEST 2025 / 2026 UPDATE) ACTUAL EXAM/TEST QUESTIONS AND 100% VERIFIED ANSWERS| A+ GRADE FORM A,B&C

NGN_ATI_RN_VATI_COMPREHENSIVE_PREDICTOR_2025_(LAT
EST_2025_/_2026_UPDATE)_ACTUAL_EXAM/TEST_QUESTIONS_
AND_100%_VERIFIED_ANSWERS|_A+_GRADE_FORM_A,B&C

FORM_A_-_ATI_RN_VATI_COMPREHENSIVE_PREDICTOR_2025



Q1._A_client_with_CHF_is_on_furosemide_and_digoxin._Which_finding_should_the_n
urse_report_immediately?
A. Serum_potassium_3.0_mEq/L
B. Digoxin_level_1.0_ng/mL
C. Oxygen_saturation_95%_on_room_air
D. Crackles_in_lung_bases
Answer:_A._Serum_potassium_3.0_mEq/L
Rationale:_Hypokalemia_predisposes_to_digoxin_toxicity_and_dysrhythmias._Digo
xin_level_is_within_normal,_O2_sat_95%_is_adequate,_crackles_are_expected_but_not_
as_urgent.
Q2._The_nurse_admits_a_client_with_pulmonary_edema_due_to_CHF._Which_initial_
action_should_the_nurse_take?
A. Restrict_fluids_to_1,200_mL/day
B. Place_the_client_in_high_Fowler’s_position
C. Insert_an_indwelling_urinary_catheter
D. Prepare_to_administer_furosemide_IV
Answer:_B._Place_the_client_in_high_Fowler’s_position
Rationale:_Positioning_improves_oxygenation_immediately._Medications_and_fluid

,restriction_come_after_airway_optimization.
Q3._A_nurse_teaches_a_client_about_digoxin._Which_statement_indicates_a_need_for_furt
her_teaching?
A. “I_will_take_my_pulse_before_each_dose.”
B. “If_I_feel_nauseated,_I_will_stop_the_medication.”
C. “I_will_take_my_medication_at_the_same_time_each_day.”
D. “If_my_vision_becomes_blurred,_I’ll_call_my_provider.”_
Answer:_B._“If_I_feel_nauseated,_I_will_stop_the_medication.
”
Rationale:_Client_should_report_symptoms_to_provider,_not_stop_medication_abrupt
ly.
Q4._The_nurse_observes_a_client_with_CHF_developing_acute_dyspnea_and_frothy_sp
utum._Which_intervention_is_priority?
A. Notify_the_provider
B. Increase_oxygen_flow_rate
C. Place_client_upright_with_legs_dangling
D. Prepare_for_morphine_administration
Answer:_C._Place_client_upright_with_legs_dangling
Rationale:_Position_improves_gas_exchange_and_reduces_preload_immediately.
Q5._Which_laboratory_finding_should_the_nurse_monitor_closely_in_a_client_receivin
g_furosemide?
A. Hemoglobin
B. Potassium
C. Sodium
D. Glucose

,Answer:_B._Potassium
Rationale:_Loop_diuretics_cause_potassium_loss,_increasing_risk_for_dysrhythmias._
Case_Study_2:_Preeclampsia
Q6._A_pregnant_client_at_34_weeks_with_preeclampsia_is_receiving_magnesium_sul
fate._Which_finding_requires_immediate_action?
A. Urine_output_25_mL/hr
B. BP_150/98_mmHg
C. Fetal_heart_rate_140/min
D. Reflexes_+3
Answer:_A._Urine_output_25_mL/hr
Rationale:_Oliguria_indicates_risk_for_magnesium_toxicity_since_the_drug_is_renally_
excreted.
Q7._Which_of_the_following_is_the_antidote_for_magnesium_sulfate_toxicity?
A. Calcium_gluconate
B. Sodium_bicarbonate
C. Naloxone
D. Atropine
Answer:_A._Calcium_gluconate
Rationale:_Calcium_gluconate_reverses_CNS_and_respiratory_depression_caused_by_ma
gnesium.
Q8._A_client_on_magnesium_sulfate_reports_feeling_flushed_and_warm._What_should
_ the_nurse_do?
A. Stop_the_infusion_immediately
B. Document_the_finding_as_expected

, C. Administer_calcium_gluconate
D. Notify_the_provider
Answer:_B._Document_the_finding_as_expected
Rationale:_Flushing_and_warmth_are_common_side_effects,_not_toxicity.
Q9._Which_of_the_following_fetal_monitoring_patterns_indicates_uteroplacental_insuffici
ency?
A. Variable_decelerations
B. Late_decelerations
C. Early_decelerations
D. Accelerations
Answer:_B._Late_decelerations
Rationale:_Late_decelerations_reflect_poor_placental_perfusion_and_oxygen_deliver
y_to_the_fetus.
Q10._Which_of_the_following_vaccines_is_contraindicated_during_pregnancy?
A. Tdap
B. Hepatitis_B
C. MMR
D. Influenza_(inactivated)
_ Answer:_C._MMR
Rationale:_MMR_is_a_live_vaccine_and_contraindicated_during_pregnancy._
Case_Study_3:_Psychiatric_Nursing
Q11._A_client_with_major_depressive_disorder_expresses_suicidal_ideation._Which_is
_ the_priority_intervention?
A. Establish_a_no-suicide_contract